Bahrain's National Health Regulatory Authority (NHRA) has approved "Sotrovimab" for emergency use, a new drug by GlaxoSmithKline (GSK) for the treatment of Covid-19. The decision to add "Sotrovimab" to Covid-19 treatment protocols follows emergency use approval by the US Food and Drug Administration (FDA) as well a comprehensive review of GSK's clinical trials, said a Bahrain News Agency report. “Sotrovimab-VIR-7831” develops “monoclonal antibodies” and will be used to treat infected ...